US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

270.91

+20.508.19%

Post-market: 268.40-2.5100-0.93%19:53 EDT

Volume:432.73K

Turnover:117.22M

Market Cap:534.91M

PE:- -

High:280.62

Open:264.34

Low:263.72

Close:250.41

52wk High:341.93

52wk Low:77.07

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.70

T/O Rate:21.92%

Dividend:1.00

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures

Health Care Roundup: Market Talk

HealthCo REIT Director Increases Stake Under Board Unit Plan

Fisher & Paykel Healthcare Issues New Unquoted Employee Options

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett

EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident

MT Newswires Live

Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA

MT Newswires Live

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Tenet Healthcare Prices Upsized $2 Billion Notes Offering

MT Newswires Live

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

Health Care Roundup: Market Talk

Intellia’s Lonvo-z Gains FDA Priority Review for HAE

Cycurion Secures New Healthcare and Public Health Contracts

Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":270.91,"timestamp":1789675200000,"preClose":250.41,"halted":0,"volume":432727,"hourTrading":{"tag":"盘后","latestPrice":268.4,"preClose":270.91,"latestTime":"19:53 EDT","volume":2204,"amount":593186.496,"timestamp":1789689238953,"change":-2.51,"changeRate":-0.009265,"amplitude":0.009265},"delay":0,"changeRate":0.08186574018609492,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Closed","change":20.5,"latestTime":"09-17 16:00:00 EDT","open":264.34,"high":280.62,"low":263.72,"amount":117220941.03029999,"amplitude":0.067489,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.41,"sharesOutstanding":3074486,"nav":250.701,"aum":495005121.34,"dividendRate":0.003697,"bidAskSpread":0.003409,"preHourTrading":{"tag":"盘前","latestPrice":264.96,"preClose":250.41,"latestTime":"09:28 EDT","volume":3396,"amount":879022.60968,"timestamp":1789651729052,"change":14.55,"changeRate":0.058105,"amplitude":0.043329},"postHourTrading":{"tag":"盘后","latestPrice":268.4,"preClose":270.91,"latestTime":"19:53 EDT","volume":2204,"amount":593186.496,"timestamp":1789689238953,"change":-2.51,"changeRate":-0.009265,"amplitude":0.009265},"volumeRatio":1.698681,"impliedVol":0.9474,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.698681,"shares":1974486,"dividePrice":1.0016,"high":280.62,"amplitude":0.067489,"preClose":250.41,"low":263.72,"week52Low":77.07,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":270.91,"eps":0,"divideRate":0.003697,"volume":432727,"delay":0,"ttmEps":0,"open":264.34,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":266,"twentyDayClose":341.55,"sixtyDayClose":235.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666828455","title":"Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828455","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828455?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358431/0/en/telix-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-and-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","BK4137","LU1363072403.SGD","LU0234570918.USD","LU0795875086.SGD","LU0128526141.USD","ASX","BK4141","LU0006306889.USD","BK4534","LU1074936037.SGD","XLV","LU0106831901.USD","BK4526","LU0053666078.USD","LU2089283258.USD","MS","LU0158827781.USD","LABU","LU1162221912.USD","LU0314104364.USD","LU1244550221.USD","IE00BZ1G4Q59.USD","XBI","LU0158827948.USD","BK4516","IE00B775SV38.USD","BK4127","IE00BKVL7J92.USD","LU0390134368.USD","LU0098860793.USD","BK4504","LU2487616109.SGD","LU1720051017.SGD","LU0106261372.USD","LU2347655156.SGD","LU1668664300.SGD","BK4588","LU1732800096.USD","LU1989772923.USD","TLX","LU2028103732.USD","LU1791710582.SGD","LU0557290698.USD","LU1064131342.USD","IAI","LU1244550494.USD","HCSG","KBWB","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582590","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582590?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:20","pubTimestamp":1788949241,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (ABT), Pharvaris (PHVS) and Zi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-pharvaris-phvs-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1691799644.USD","HCSG","LU0170899867.USD","LABU","LU0310799852.SGD","LU1201861249.SGD","IE00B19Z3B42.SGD","TMED","IE00B2B36J28.USD","IE0002270589.USD","LU1023059063.AUD","LU1914381329.SGD","LU0648001328.SGD","LU0234572021.USD","LU0882574055.USD","ABT","IHI","LU1670628061.USD","LU1989763690.USD","LU2237957811.SGD","LU1267930573.SGD","LU2211815571.USD","LU0432979614.USD","LU1061106388.HKD","LU0211327993.USD","ZBH","LU0130102774.USD","LU0889566641.SGD","BK4585","PHVS","SGXZ23171101.USD","XLV","BK4007","BK4082","IE00B19Z3581.USD","LU2089984988.USD","LU0980610538.SGD","LU2133065610.SGD","LU0211328371.USD","LU0029864427.USD","PJP","BK4592","LU0128526141.USD","LU0320765489.SGD","LU0114720955.EUR","LU0708994859.HKD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582848","title":"RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582848?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:00","pubTimestamp":1788948000,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Sept.  09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358410/10985/en/radnet-inc-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-on-wednesday-september-16th-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","XLV","HCSG","BK4137","BK4581","BK4585","XBI","BK4588","LU0128526141.USD","LU2065731478.USD","RDNT","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584832","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584832?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:50","pubTimestamp":1788947417,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Surrozen (SRZN), Liquidia Technologies (LQDA) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-surrozen-srzn-liquidia-technologies-lqda-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4585","BK4581","BK4185","LABU","BK4139","BK4588","HCSG","LQDA","XLV","LU0029874061.USD","SRZN","BK4007","XBI","LU0128526141.USD","UHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589965","title":"Bamboos Health Care Warns of Sharp Profit Decline Amid Competitive and Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589965","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:11","pubTimestamp":1788945080,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has issued an update. Bamboos Health Care Holdings Ltd has issued a profit warning, indicating net ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-warns-of-sharp-profit-decline-amid-competitive-and-cost-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4585","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158565","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158565?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:20","pubTimestamp":1788942000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0801 GMT - Novartis's latest clinical-trial setback raises quest","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XLV","BK4581","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666588523","title":"HealthCo REIT Director Increases Stake Under Board Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666588523","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666588523?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:08","pubTimestamp":1788937697,"startTime":"0","endTime":"0","summary":"An announcement from HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) is now available. HealthCo Healthcare & Wellness REIT disclosed a change in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-reit-director-increases-stake-under-board-unit-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDIV","DFRA","BK4588","IQRA","PSCF","REIT","RJMG","XBI","RNTY","BK4581","BPRE","YLDW","IVRA","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530127","title":"Fisher & Paykel Healthcare Issues New Unquoted Employee Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530127?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:17","pubTimestamp":1788923854,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an update. Fisher & Paykel Healthcare Corporation Limited has notified t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","BK4585","XLV","BK8004","FPH.NZ","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU1861558580.USD","LU0029874061.USD","LABU","AMGN","LU1983299246.USD","LU2242652126.USD","BEAM","SG9999001440.SGD","BK4533","LU0868494617.USD","IE0002141913.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","RPRX","PBE","IBBQ","IE00B2B36J28.USD","TBXU","BK4139","BK4534","LU0289739699.SGD","IBB","IHE","LU1861559042.SGD","BK4588","HCSG","IE00B4R5TH58.HKD","BK4137","BIB","BK4566","IE0009355771.USD","LU1061106388.HKD","XBI","BK4599","BK4505","BK4535","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4611","IE00BJT1NW94.SGD","PJP","LU1023059063.AUD","LU1057294990.SGD","BK4007","LU2242646821.SGD","XLV","LU0889565916.HKD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309940","title":"Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309940?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:06","pubTimestamp":1788919570,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst maintained a Sell rating on Ramsay Health Care today and set a price target of A$48.00. In addition to Ord Minnett, Ramsay Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4581","BK4185","RMSYF","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630529","title":"EBR Systems Says FDA Finds No Need for WiSE System Recall After Cybersecurity Incident","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630529","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630529?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:02","pubTimestamp":1788915728,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its review of the company's cybersecurity risk assessment related to the February incident and determined that no field corrective action or recall of the WiSE System is warranted, according to a Wednesday filing with the Australian bourse.The incident was classified as a controlled risk under FDA postmarket cybersecurity guidance, with no evidence of any impact on the safety or performance of fielded WiSE cardiac resynchronization therapy systems, per the filing.The company continues its cybersecurity remediation efforts by strengthening credential controls, enhancing anti-phishing measures, expanding endpoint monitoring, hardening its products, and providing required updates to the FDA, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","CIBR","BUG","BK4588","BK7007","EBR.AU","IHAK","HACK","NTSK","TEKX","BK4097","LABU","HAKY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370726","title":"Press Release: Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:59","pubTimestamp":1788904740,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) (\"Inhibitor\" or the \"Company\") today highlighted several important developments disclosed in its Quarterly Re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","BK4585","LABU","BK4139","BK4539","BK4588","R","BK4007","INTI","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370799","title":"Echo IQ's EchoSolv HF Device Deemed 'Not Substantially Equivalent' by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370799","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370799?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:58","pubTimestamp":1788904705,"startTime":"0","endTime":"0","summary":"Echo IQ  failed to secure commercial clearance for its EchoSolv HF device after the US Food and Drug Administration  found its initial 510 application  \"not substantially equivalent,\" according to an Australian bourse filing on Tuesday after market hours.The company is evaluating the US FDA's concerns with regulatory, legal, and statistical advisers and believes a potential pathway to clearance remains, per the filing.An applicant whose medical device has been deemed not substantially equivalent may resubmit another 510 application with new data, request a Class I or II designation, file a reclassification petition, or submit a premarket approval application, according to the FDA's website.The decision does not affect the FDA-cleared EchoSolv AS platform or its commercialization in the US, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","EIQ.AU","BK4585","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666704053","title":"Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666704053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666704053?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:31","pubTimestamp":1788903060,"startTime":"0","endTime":"0","summary":"Health-care companies fell after growth warnings from two major medical-device makers and a disappointing clinical trial.Shares of Novartis plunged after one of the company's leading drug candidates failed to show significant progress on a late-stage trial on sufferers of a neuromuscular condition.Medical-device maker Boston Scientific said it likely would not meet its financial guidance due to the cyberattack that has disrupted its operations.Shares of Stryker declined after the maker of orthopedic implants and other medical technology said a lack of supply continues to hamper its peripheral vascular business.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1989771016.USD","LU0267386448.USD","LU1791710582.SGD","LU2491049909.HKD","LU0238689110.USD","LU0225283273.USD","LU0823417653.USD","SG9999001176.SGD","XLV","LABU","LU1791710400.SGD","LU0122379950.USD","BK4585","BK4082","LU1720051108.HKD","IE00BJT1NW94.SGD","LU0251132253.USD","LU2362541513.USD","LU0187121727.USD","BK4504","LU1153585028.USD","LU1548497426.USD","LU1989764748.USD","LU1291159041.SGD","LU0048584097.USD","LU0353189680.USD","LU0266013472.USD","LU2362540622.SGD","LU2491050071.SGD","LU0345769631.USD","IE00B4R5TH58.HKD","LU2357305700.SGD","IE00B2B36J28.USD","LU1023059063.AUD","IE0009355771.USD","BK4581","LU1983299246.USD","LU0138981039.USD","BSX","LU0823417737.USD","LU2242649171.HKD","LU2506951958.HKD","XBI","SGXZ57979304.SGD","LU1989764664.SGD","LU0882574055.USD","LU2112291526.USD","LU2324357040.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370464","title":"Tenet Healthcare Prices Upsized $2 Billion Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370464","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370464?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:28","pubTimestamp":1788902911,"startTime":"0","endTime":"0","summary":"Tenet Healthcare  priced a private offering of $2 billion in senior notes due Sept. 15, 2034, bearing interest at 6.250% per annum, the company said late Tuesday.The offering was upsized from a previously announced $1.5 billion, with completion expected Sept. 22, the company said.Tenet said proceeds, along with cash on hand, will fund redemption of $1.5 billion of its 5.125% notes due 2027 and partial redemption of $500 million of its 6.125% notes due 2028.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","LU1201861165.SGD","HCSG","BK4137","XLV","BK4581","BK4585","LU0130103400.USD","XBI","LU0963586101.USD","BK4588","LU0128526141.USD","LU0648000940.SGD","THC.AU","LU0029874061.USD","BK4185","LABU","THC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666689370","title":"Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666689370","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666689370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:05","pubTimestamp":1788901500,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Ser","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358168/0/en/strata-critical-to-present-at-the-2026-jefferies-healthcare-services-and-technology-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","LABU","XLV","XBI","BK4588","LU0029874061.USD","BK4137","LU0128526141.USD","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370898","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370898?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:50","pubTimestamp":1788900600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0417 ET - Novartis's latest clinical-trial failure suggests the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","XLV","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666772143","title":"Intellia’s Lonvo-z Gains FDA Priority Review for HAE","url":"https://stock-news.laohu8.com/highlight/detail?id=2666772143","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666772143?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:35","pubTimestamp":1788899708,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics ( ($NTLA) ) has shared an update. On September 8, 2026, Intellia Therapeutics announced that the U.S. Food and Drug Administr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intellias-lonvo-z-gains-fda-priority-review-for-hae?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intellias-lonvo-z-gains-fda-priority-review-for-hae?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169589451.USD","LU0106261612.USD","HAE","LU0205194284.USD","LU1169590202.USD","BK4585","LABU","LU0205193047.USD","IE00B64QTZ34.USD","BK4198","IE00B19Z6F94.USD","IE00BLDYK493.USD","LU0012050646.USD","BK4588","IE0034390439.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372275","title":"Cycurion Secures New Healthcare and Public Health Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372275?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:47","pubTimestamp":1788896876,"startTime":"0","endTime":"0","summary":"Cycurion ( ($CYCU) ) has shared an update. On September 3, 2026, Cycurion announced new engagements totaling about $800,000 in annual contract spen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","HCSG","CYCU","BK4585","LABU","BK4588","BK4137","LU0029874061.USD","XBI","XLV","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372293","title":"Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372293","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372293?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:45","pubTimestamp":1788896725,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a Buy ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","BK4581","BK4588","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":15,"totalSize":398,"code":"91000000","status":"200"}]}}